Stryker (SYK) Stock Hits 52-Week Low After Wells Fargo Cuts Price Target
TLDR
- Stryker (SYK) dropped 8.9% to a new 52-week low of $275.10 on Wednesday
- Wells Fargo cut its price target from $418 to $348 while keeping an Overweight rating
- The firm lowered its 2026 revenue estimate to $27,209M, below Stryker’s own guidance range
- Analysts still hold a “Moderate Buy” consensus with an average target of $386.28
- Insiders sold over 351,000 shares worth roughly $118.2 million in the last quarter
Stryker (SYK) fell 8.9% to $276.16 on Wednesday, touching a new 52-week low of $275.10 during the session. The stock is now trading well below its 50-day moving average of $327.52 and its 200-day moving average of $328.30.
The selloff came after Wells Fargo trimmed its price target on SYK to $348 from $418, though the firm held its Overweight rating. The cut followed Stryker’s appearance at the 2026 Wells Fargo Healthcare Conference in Boston, where CFO Preston Wells and VP of Investor Relations Nick Mead represented the company.
Wells Fargo lowered its 2026 revenue estimate to $27,209 million from $27,325 million. That implies organic growth of 8.1%, which sits below Stryker’s own guidance range of 8.3% to 9.3%.
… Continue reading the full article at the original source below.
